Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

AstraZeneca announced that its drug Lynparza (olaparib) has been approved for use in Scotland. The approval by the Scottish ...

Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower ...

Medical experts through out di world dey wonder say cancer cases dey increase in younger pipo wey di disease no dey dia ...

It is known as the 'Celtic Curse', a potentially fatal genetic condition which has an unusually high prevalence among those ...

Jewish Genetic Screening Awareness Week is very important in educating the public and advocating for widespread screening.

Cancer has been regarded traditionally as a disease of aging. Routine screening for cancer is advised for individuals aged 40 ...

Breast cancers can be classified into subgroups that hint at the aggressiveness of the cancer and the likelihood that the ...

Talazoparib plus enzalutamide boosts overall survival in metastatic castration-resistant prostate cancer, with HRR-deficient ...

Breast cancers at all stages are defined by the structure of their genomes, researchers find. Targeting these processes early is likely to offer unexpected therapeutic avenues.

Real-world data highlight gaps in genetic testing and targeted therapy use for metastatic castration-resistant prostate ...